We have some exciting news to share on this Monday morning. We are very pleased to announce that Steven D. Leach, MD, Director of the Dartmouth Cancer Center and the Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer at Dartmouth’s Geisel School of Medicine, has been elected to the prestigious National Academy of Medicine (NAM) .
As many of you know, election to the National Academy of Medicine is considered one of the highest honors in the fields of healthcare and medicine, recognizing individuals who have demonstrated outstanding professional achievement and commitment to service. Just 100 new members are elected each year and this year’s cohort was announced earlier today at NAM’s annual meeting in Washington, DC.
You can read the media release here.
Dr. Leach was elected to the National Academy of Medicine for his international leadership in the field of pancreatic cancer research over the past three decades including his work at the Leach Laboratory . Prior to joining Dartmouth Health and Geisel in 2017, he directed Memorial Sloan Kettering's Rubenstein Center for Pancreatic Cancer Research, and also served as Professor of Surgery, Oncology and Cell Biology at Johns Hopkins.
Among Steve’s many scientific contributions and professional honors, he was named a Fellow of the American Academy for the Advancement of Science in 2018, and was elected to the Board of the Association of American Cancer Institutes in 2022. He has also served as chair of the Pancreatic Cancer Action Network’s Scientific and Medical Advisory Board and as a member of the Princeton University Board of Trustees.
We hope you will join us in congratulating Steve on this distinguished honor. We are proud to have him leading Dartmouth Cancer Center and educating and mentoring the next generation of clinicians and researchers.
Duane Compton, PhD, Dean, Dartmouth Geisel School of Medicine
Joanne M. Conroy, MD, CEO and President, Dartmouth Health